论文部分内容阅读
本文对治疗隐睾进行了前瞻性研究，共９１例１１２侧隐睾，年龄为１～１３岁，随机分为４组。研究结果表明，促黄体生成素释放激素滴鼻加绒毛膜促性腺激素肌注，睾丸完全下降率为３６．８％，部分下降率为３６．８％；促黄体生成素释放激素皮下注射加绒毛膜促性腺激素肌注，睾丸完全下降率１８．９％，部分下降率为２９．７％，两组存在显著差异；低剂量绒毛膜促性腺激素（６０００Ｕ／疗程）治疗隐睾疗效不显著，阴囊发育状况和血清睾丸酮水平有关。
In this paper, a prospective study of the treatment of cryptorchidism, a total of 91 cases of 112 sides of cryptorchidism, aged 1 to 13 years old, were randomly divided into 4 groups. The results showed that the luteinizing hormone releasing hormone intranasal and chorionic gonadotropin intramuscular injection, the testicular complete decline rate was 36.8%, the partial reduction rate was 36.8%; luteinizing hormone releasing hormone subcutaneous injection plus fluff Membrane gonadotrophin intramuscular injection, testicular complete decline rate of 18.9%, partial reduction rate of 29.7%, there were significant differences between the two groups; low-dose chorionic gonadotropin (6000U / treatment) treatment of cryptorchidism was not significant, Scrotal development and serum testosterone levels.